WEBSITE BSE:539433 NSE: INDOGLOBAL Inc. Year: 1985 Industry: Hospital & Healthcare Services My Bucket: Add Stock
Last updated: 00:00
No Notes Added Yet
Indo-Global Enterprises Ltd is an Indian public limited company incorporated in 1990 and headquartered in Mumbai, Maharashtra. The company operates in the manufacturing and trading sector, specializing in the production and distribution of industrial chemicals, specialty chemicals, and related products used in industries such as pharmaceuticals, textiles, paints, adhesives, and construction. Its product portfolio includes solvents, chemical intermediates, and customized chemical formulations that meet domestic and international quality standard...Read More
Indo-Global Enterprises Ltd is an Indian public limited company incorporated in 1990 and headquartered in Mumbai, Maharashtra. The company operates in the manufacturing and trading sector, specializing in the production and distribution of industrial chemicals, specialty chemicals, and related products used in industries such as pharmaceuticals, textiles, paints, adhesives, and construction. Its product portfolio includes solvents, chemical intermediates, and customized chemical formulations that meet domestic and international quality standards. Indo-Global Enterprises Ltd serves clients across India and in export markets, focusing on product quality, timely delivery, and customer service. The company is listed on Indian stock exchanges and continues to expand its presence in the chemicals and industrial materials sector. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹10 Cr.
Stock P/E -24.4
P/B 1.8
Current Price ₹16
Book Value ₹ 9
Face Value 10
52W High ₹0
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Adjusted Earnings Per Share | -0.4 | -0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.2 | -0.1 | -0.1 | -0.1 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 1 | 0 | 1 | 1 | 9 | 2 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 1 | 0 | 1 | 1 | 9 | 2 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 8 | 2 | 0 | 1 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | -0 | -0 | -0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -0 | -0 | -0 | 0 |
| Provision for Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -0 | -1 | -0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -0 | -1 | -0 | 0 |
| Adjusted Earnings Per Share | 1.1 | 2.7 | 0.5 | 0.8 | 0 | 1 | 0.4 | -0.1 | -1.2 | -0.7 | -0.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | -100% | -100% | 0% |
| Operating Profit CAGR | 0% | -100% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 0% | 0% | -3% | 2% |
| ROE Average | -7% | -6% | -1% | 3% |
| ROCE Average | -2% | -3% | 2% | 6% |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1 | 1 | 1 | 1 | 7 | 8 | 8 | 8 | 7 | 7 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 2 | 6 | 2 | 1 | 2 | 1 |
| Total Liabilities | 1 | 1 | 1 | 1 | 10 | 15 | 11 | 10 | 9 | 8 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 9 | 9 | 8 |
| Total Current Assets | 0 | 0 | 0 | 0 | 8 | 15 | 1 | 0 | 0 | 0 |
| Total Assets | 1 | 1 | 1 | 1 | 10 | 15 | 11 | 10 | 9 | 8 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | 0 | 0 | -0 | -0 | -4 | -2 | -2 | 1 | 0 | -0 |
| Cash Flow from Investing Activities | -0 | -0 | -0 | -0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Cash Flow from Financing Activities | -0 | -0 | -0 | 0 | 6 | 1 | -0 | -1 | -0 | 0 |
| Net Cash Inflow / Outflow | 0 | 0 | -0 | -0 | 2 | 0 | -2 | 0 | -0 | 0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 |
| # | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.13 | 2.72 | 0.48 | 0.77 | 0.05 | 0.96 | 0.4 | -0.13 | -1.24 | -0.66 |
| CEPS(Rs) | 1.59 | 3.21 | 1.03 | 1.25 | 0.07 | 0.96 | 0.4 | -0.13 | -1.24 | -0.66 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 11.17 | 13.89 | 14.37 | 15.14 | 10.25 | 11.21 | 11.61 | 11.48 | 10.24 | 9.58 |
| Core EBITDA Margin(%) | 13.16 | 13.97 | -1.63 | 7.23 | 6.37 | 10.17 | 27.8 | -39.08 | 0 | 0 |
| EBIT Margin(%) | 10.76 | 12.75 | 5.19 | 9.27 | 8.42 | 10.16 | 30.27 | -38.25 | 0 | 0 |
| Pre Tax Margin(%) | 8.29 | 10.93 | 3.63 | 8.51 | 8.27 | 9.99 | 16.68 | -49.32 | 0 | 0 |
| PAT Margin (%) | 5.92 | 11.8 | 2.66 | 3.64 | 5.94 | 6.83 | 10.87 | -27.38 | 0 | 0 |
| Cash Profit Margin (%) | 8.35 | 13.93 | 5.69 | 5.92 | 8.64 | 6.85 | 10.92 | -27.38 | 0 | 0 |
| ROA(%) | 1.95 | 4.57 | 0.8 | 1.3 | 0.57 | 4.95 | 1.97 | -0.79 | -8.45 | -4.87 |
| ROE(%) | 10.1 | 21.74 | 3.41 | 5.21 | 0.91 | 8.94 | 3.53 | -1.1 | -11.46 | -6.61 |
| ROCE(%) | 13.92 | 18.78 | 5.79 | 12.61 | 1.29 | 11.33 | 7.95 | -1.44 | -5.83 | -2.27 |
| Receivable days | 13.04 | 9.87 | 17.11 | 17.41 | 7.72 | 39.56 | 179 | 461.42 | 0 | 0 |
| Inventory Days | 10.86 | 10.89 | 15.41 | 14.19 | 0 | 41.66 | 0 | 0.41 | 0 | 0 |
| Payable days | 11.83 | 31.76 | 28.31 | 2.04 | 1.13 | 3.14 | 41.09 | 213.25 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 51.96 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 1.8 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.6 | 0.4 | 0.57 | 0.44 | 8.52 | 0.73 | 6.09 | 21.48 | 0 | 0 |
| EV/Core EBITDA(x) | 4.52 | 2.71 | 6.87 | 3.84 | 76.68 | 7.17 | 20.1 | -56.16 | -15.83 | -45.13 |
| Net Sales Growth(%) | 0 | 21.11 | -21.46 | 16.45 | 1.93 | 1595.4 | -73.63 | -87.44 | -100 | 0 |
| EBIT Growth(%) | 0 | 43.49 | -68.02 | 107.85 | -7.44 | 1945.92 | -21.39 | -115.87 | -257.01 | 63.8 |
| PAT Growth(%) | 0 | 141.53 | -82.33 | 59.77 | 66.29 | 1848.85 | -58.05 | -131.64 | -878.03 | 47.35 |
| EPS Growth(%) | 0 | 141.53 | -82.33 | 59.77 | -93.6 | 1848.85 | -58.05 | -131.65 | -877.8 | 47.35 |
| Debt/Equity(x) | 0.32 | 0.19 | 0.11 | 0 | 0 | 0.33 | 0.14 | 0 | 0.01 | 0.04 |
| Current Ratio(x) | 1.24 | 1.22 | 1.43 | 1.88 | 4.04 | 2.31 | 0.28 | 0.29 | 0 | 0.01 |
| Quick Ratio(x) | 1.05 | 1.06 | 1.22 | 1.52 | 4.04 | 2.16 | 0.28 | 0.29 | 0 | 0.01 |
| Interest Cover(x) | 4.35 | 7.02 | 3.32 | 12.3 | 58.07 | 61.87 | 2.23 | -3.45 | -4.3 | -2.11 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 |
| # | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 97.18 | 97.18 | 97.18 | 97.18 | 97.18 | 97.18 | 97.18 | 97.18 | 97.18 | 97.18 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
